Among these pathways, NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) plays a pivotal role in linking NASH to inflammation, macrophage polarization, and fibrosis. Here, NFKB1 is linked to metabolic dysfunction-associated steatohepatitis.